The amino acid transporter SLC7A11 expression in breast cancer-Reference-Cited by-同舟云学术

The amino acid transporter SLC7A11 expression in breast cancer

Published:2023-12-10 Issue:1 Volume:25 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Nath Preyanka¹,Alfarsi Lutfi H.¹,El-Ansari Rokaya¹,Masisi Brendah K.¹,Erkan Busra¹,Fakroun Ali¹,Ellis Ian O.¹²,Rakha Emad A.¹²,Green Andrew R.¹^ORCID

Affiliation:

1. Nottingham Breast Cancer Research Centre, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, UK

2. Cellular Pathology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK

Funder

there is no funding

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2291855

Reference79 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. A new genome-driven integrated classification of breast cancer and its implications

3. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies

4. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer;Cancers;2024-07-15

2. SLC7A11: the Achilles heel of tumor?;Frontiers in Immunology;2024-07-08

3. Fucoxanthin Induces Ferroptosis in Cancer Cells via Downregulation of the Nrf2/HO−1/GPX4 Pathway;Molecules;2024-06-14

4. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches;International Journal of Molecular Sciences;2024-02-22

5. Long Non-Coding RNA NORAD Suppresses Erastin-Induced Ferroptosis in Breast Cancer by Upregulating SLC7A11 Via Targeting the FUS/NR3C1 Axis;2024